Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use
In 2013, rituximab was approved in France for the treatment of ANCA-associated vasculitis (AAV). The aim of the study was to compare the treatment and health events of adult incident patients with granulomatos...